Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective

Recent developments in prostate-specific membrane antigen (PSMA) targeted diagnostic imaging and therapeutics (theranostics) promise to advance the management of primary, biochemically recurrent, and metastatic prostate cancer. In order to maximize the clinical impact of PSMA-targeted theranostics,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Thomas S. C., Gao, Xin, Salari, Keyan, Zlatev, Dimitar V., Heidari, Pedram, Kamran, Sophia C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355555/
https://www.ncbi.nlm.nih.gov/pubmed/34395293
http://dx.doi.org/10.3389/fonc.2021.722277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355555/
https://www.ncbi.nlm.nih.gov/pubmed/34395293
http://dx.doi.org/10.3389/fonc.2021.722277

Ejemplares similares